Photodynamic therapy (PDT) has received increased attention since the regulatory approvals have been granted to several photosensitizing drugs and light applicators worldwide. Much progress has been seen in basic sciences and clinical photodynamics in recent years. This review will focus on new developments of clinical investigation and discuss the usefulness of various forms of PDT techniques for curative or palliative treatment of malignant and non-malignant diseases.
LipsonR. L., BaldesE. J.Hematoporphyrin Derivative: A New Aid for Endoscopic Detection of Malignant Disease. J. Thorac. Cardiovasc. Surg.42, 623–629 (1961).
2.
DoughertyT. J., HendersonB. W., SchwartzS., WinkelmanJ. W., LipsonR. L. In Historical Perspective in Photodynamic Therapy, pp. 1–18, Eds., HendersonB. W. and DoughertyT. J.Maurice Dekker, New York (1992).
3.
DoughertyT. J., GrindeyG. B., FielR., WeishauptK. R., BoyleD. G.Photoradiation Therapy II. Cure of Animal Tumors with Hematoporphyrin and Light. J. Natl. Cancer Inst.55, 115–121 (1975).
4.
DoughertyT. J., KaufmanJ. E., GoldfarbA., WeishauptK. R., BoyleD., MittlemanA.Photoradiation Therapy for the Treatment of Malignant Tumors. Cancer Res.38, 2628–2635 (1978).
5.
DoughertyT. J., LawrenceG., KaufmanJ. H., BoyleD., WeishauptK.R., GoldfarbA.Photoradiation in the Treatment of Recurrent Breast Carcinoma. J. Natl. Cancer Inst.62, 231–237 (1979).
6.
DoughertyT. J., GomerC. J., HendersonB. W., JoriG., KesselD., KorbelikM., MoanJ., PengQ.Photodynamic Therapy. J. Natl. Cancer Inst.90, 899–905 (1998).
7.
AckroydR., KeltyC., BrownN., ReedM.The History of Photodetection and Photodynamic Therapy. Photochem. Photobiol.74, 656–669 (2001).
AlmeidaR. D., ManadasB. J., CarvalhoA. P., DuarteC. B.Intracellular Signaling Mechanisms in Photodynamic Therapy. Biochim. Biophys. Acta1704, 59–86 (2004).
11.
BrownS. B., BrownE. A., WalkerI.The Present and Future Role of Photodynamic Therapy in Cancer Treatment. Lancet Oncol.5, 497–508 (2004).
12.
SolbanN., OrtelB., PogueB., HasanT.Targeted Optical Imaging and Photodynamic Therapy. Ernst Schering Res Found Workshop. 49, 229–258 (2005).
13.
CastanoA. P., NemidovaT. N., HamblinM. R.Mechanisms in Photodynamic Therapy: Part I – Photosensitizers, Photochemistry and Cellular Location. Photodiag. Photodyn. Therapy (in press) (2005).
14.
CastanoA. P., NemidovaT. N., HamblinM. R.Mechanisms in Photodynamic Therapy: Part II – Cellular Signaling, Cell Metabolism and Modes of Cell Death. Photodiag. Photodyn. Therapy (in press) (2005).
15.
MoserJ. G.Definitions and General Properties of 2nd & 3rd Generation Photosensitizers. In Photodynamic Tumor Therapy - 2nd & 3rd Generation Photosensitizers, pp. 3–8, Ed., MoserJ. G.Harwood Academic Publishers, London (1997).
16.
AllisonR. R., DownieG. H., CuencaR., HuX. H., ChildsC. J. H., SibataC. H.Photosensitizers in Clinical PDT. Photodiag. Photodyn. Therapy1, 27–42 (2004).
17.
DettyM. R., GibsonS. L., WagnerS. J.Current Clinical and Preclinical Photosensitizers for Use in Photodynamic Therapy. J. Med. Chem.47, 3897–3915 (2004).
18.
SchmidtM. H., BajicD. M., ReichertK. W.II, MartinT. S., MeyerG. A., WhelanH. T.Light-emitting Diodes as a Light Source for Intraoperative Photodynamic Therapy. Neurosurgery38, 552–556 (1996).
19.
LustigR. A., VoglT. J., FrommD., CuencaR., HisA. R., D'CruzA. K., KrajinaZ., TuricM., SinghalA., ChenJ. C.A Multicenter Phase I Safety Study of Intratumoral Photoactivation of Talaporfin Sodium in Patients with Refractory Solid Tumors. Cancer98, 1767–1771 (2003).
20.
ChenJ., KeltnerL., ChristophersenJ., ZhengF., KrouseM., SinghalA., WangS. S.New Technology for Deep Light Distribution in Tissue for Phototherapy. Cancer J.8, 154–163 (2002).
21.
JuzenieneA., JuzenasP., MaL. W., IaniV., MoanJ.Effectiveness of Different Light Sources for 5-aminolevulinic Acid Photodynamic Therapy. Lasers Med. Sci.19, 139–149 (2004).
22.
MangT. S.Lasers and Light Sources for PDT: Past, Present and Future. Photodiag. Photodyn. Therapy1, 43–48 (2004).
23.
LowdellC. P., AshD. V., DriverI., BrownS. B.Interstitial Photodynamic Therapy. Clinical Experience with Diffusing Fibres in the Treatment of Cutaneous and Subcutaneous Tumours. Br. J. Cancer.67, 1398–403 (1993).
24.
KennedyJ. C., PottierR. H.Endogenous Protoporphyrin IX, A Clinically Useful Photosensitizer for Photodynamic Therapy. J. Photochem. Photobiol. B: Biol.14, 275–292 (1992).
25.
Fink-PuchesR., HoferA., SmolleJ., KerlH., WolfP.Primary Clinical Response and Long-term Follow-up of Solar Keratoses Treated with Topically Applied 5-aminolevulinic Acid and Irradiation by Different Wave Bands of Light. J. Photochem. Photobiol. B: Biol.41, 145–151 (1997).
RobinsonD. J., CollinsP., StringerM. R., VernonD. I., StablesG. I., BrownS. B., Sheehan-DareR. A.Improved Response of Plaque Psoriasis after Multiple Treatments with Topical 5-aminolaevulinic Acid Photodynamic Therapy. Acta Dermato-Venereol.79, 451–455 (1999).
28.
StenderI. M., NaR., FoghH., GluudC., WulfH. C.Photodynamic Therapy with 5-aminolaevulinic Acid or Placebo for Recalcitrant Foot and Hand Warts: Randomised Double-blind Trial. Lancet355, 963–966 (2000).
29.
HongcharuW., TaylorC. R., ChangY., AghassiD., SuthamjariyaK., AndersonR. R.Topical ALA-photodynamic Therapy for the Treatment of Acne Vulgaris. J. Investig. Dermatol.115, 183–192 (2000).
30.
StenderI. M., Lock-AndersenJ., WulfH. C.Recalcitrant Hand and Foot Warts Successfully Treated with Photodynamic Therapy with Topical 5-aminolaevulinic Acid: A Pilot Study. Clin. Exp. Dermatol.24, 154–159 (1999).
31.
CairnduffF., StringerM. R., HudsonE. J., AshD. V., BrownS. B.Superficial Photodynamic Therapy with Topical 5-aminolaevulinic Acid for Superficial Primary and Secondary Skin Cancer. Br. J. Cancer69, 605–608. (1994).
32.
StablesG. I., StringerM. R., RobinsonD. J., AshD. V.Large Patches of Bowen's Disease Treated by Topical Aminolaevulinic Acid Photodynamic Therapy. Br. J. Dermatol.136, 957–960 (1997).
33.
MortonC. A., WhitehurstC., McCollJ. H., MooreJ. V., MacKieR. M.Photodynamic Therapy for Large or Multiple Patches of Bowen Disease and Basal Cell Carcinoma. Arch. Dermatol.137, 319–324 (2001).
34.
LemanJ. A., DickD. C., MortonC. A.Topical 5-ALA Photodynamic Therapy for the Treatment of Cutaneous T-cell Lymphoma. Clin. Exp. Dermatol.27, 516–518 (2002).
35.
HorioT., HorioO., Miyauchi-HashimotoH., OhnukiM., IseiT.Photodynamic Therapy of Sebaceous Hyperplasia with Topical 5-aminolaevulinic Acid and Slide Projector. Br. J. Dermatol.148, 1274–1276 (2003).
36.
CoorsE. A., von den DrieschP.Topical Photodynamic Therapy for Patients with Therapy-resistant Lesions of Cutaneous T-cell Lymphoma. J. Am. Acad. Dermatol.50, 363–367 (2004).
37.
GoldM. H., BradshawV. L., BoringM. M., BridgesT. M., BironJ. A., LewisT. L.Treatment of Sebaceous Gland Hyperplasia by Photodynamic Therapy with 5-aminolevulinic Acid and a Blue Light Source or Intense Pulsed Light SourceJ. Drugs Dermatol.3, S6–S9 (2004).
38.
OseroffA. R., ShiehS., FrawleyN. P., CheneyR., BlumensonL. E., PivnickE. K., BellnierD. A.Treatment of Diffuse Basal Cell Carcinomas and Basaloid Follicular Hamartomas in Nevoid Basal Cell Carcinoma Syndrome by Wide-area 5-aminolevulinic Acid Photodynamic Therapy. Arch. Dermatol.141, 60–67 (2005).
39.
Calzavara-PintonP. G., SzeimiesR. M., OrtelB., ZaneC.Photodynamic Therapy with Systemic Administration of Photosensitizers in Dermatology. J. Photochem. Photobiol. B: Biol.36, 225–231 (1996).
40.
HuntD. W.Rostaporfin (Miravant Medical Technologies). IDrugs5, 180–186 (2002).
41.
SchuhM., NseyoU. O., PotterW. R., DaoT. L., DoughertyT. J.Photodynamic Therapy for Palliation of Locally Recurrent Breast Carcinoma. J. Clin. Oncol.5, 1766–1770 (1987).
42.
SperdutoP. W., DeLaneyT. F., ThomasG., SmithP., DachowskiL. J., RussoA., BonnerR, GlatsteinE.Photodynamic Therapy for Chest Wall Recurrence in Breast Cancer. Int. J. Radiat. Oncol. Biol. Phys.21, 441–446 (1991).
43.
WyssP., SchwarzV., Dobler-GirdziunaiteD., HornungR., WaltH., DegenA., FehrM.Photodynamic Therapy of Locoregional Breast Cancer Recurrences Using a Chlorin-type Photosensitizer. Int. J. Cancer.93, 720–724 (2001).
44.
LimJ. I.Photodynamic Therapy for Choroidal Neovascular Disease: Photosensitizers and Clinical Trials. Ophthalmol. Clin. North Am.15, 473–478 (2002).
45.
KeamS. J., ScottL. J., CurranM. P.Verteporfin: A Review of its Use in the Management of Subfoveal Choroidal Neovascularistion. Drug63, 2521–2554 (2003).
46.
BesslerN. M.VAM Study Writing Committee. Verteporfin Therapy in Age-related Macular Degeneration (VAM): An Open-label Multicenter Photodynamic Therapy Study of 4,435 Patients. Retina. 24, 512–520 (2004).
47.
SinghA. D., KaiserP. K., SearsJ. E., GuptaM., RundleP. A., RennieI. G.Photodynamic Therapy of Circumscribed Choroidal Haemangioma. Br. J. Ophthalmol. 88, 1414–1418 (2004).
48.
BielM. A.Photodynamic Therapy and the Treatment of Head and Neck Neoplasia. Laryngoscope108, 1259–1268 (1998).
49.
FeyhJ.Photodynamic Therapy for Cancers of the Head and Neck. J. Photochem. Photobiol. B: Biol.36, 175–177 (1996).
50.
LouP. J., JonesL., HooperC.Clinical Outcomes of Photodynamic Therapy for Head-and-neck Cancer. Technol. Cancer Res. Treat.2, 311–317 (2003).
51.
D'CruzA. K., RobinsonM. H., BielM. A.mTHPC-mediated Photodynamic Therapy in Patients with Advanced, Incurable Head and Neck Cancer: A Multicenter Study of 128 Patients. Head Neck26, 232–40 (2004).
52.
CopperM. P., TanI. B., OppelaarH., RuevekampM. C., StewartF. A.Meta-tetra(hydroxyphenyl)chlorin Photodynamic Therapy in Early-stage Squamous Cell Carcinoma of the Head and Neck. Arch. Otolaryngol. Head Neck Surg.129, 709–711 (2003).
EljamelM. S.New Light on the Brain: The Role of Photosensitizing Agents and Laser Light in the Management of Invasive Intracranial Tumors. Technol. Cancer Res. Treat.2, 303–309 (2003).
58.
YangV. X., MullerP. J., HermanP., WilsonB. C.A Multispectral Fluorescence Imaging System: Design and Initial Clinical Tests in Intra-operative Photofrin-photodynamic Therapy of Brain Tumors. Lasers Surg. Med.32, 224–232 (2003).
59.
StylliS. S., HowesM., MacGregorL., RajendraP., KayeA. H.Photodynamic Therapy of Brain Tumours: Evaluation of Porphyrin Uptake Versus Clinical Outcome. J. Clin. Neurosci. 11, 584–596 (2004).
FriesenS. A., HjortlandG. O., MadsenS. J., HirschbergH., EngebratenO., NeslandJ. M., PengQ.5-Aminolevulinic Acid-based Photodynamic Detection and Therapy of Brain Tumors. Int. J. Oncol.21, 577–582 (2002).
62.
BislandS. K., LilgeL., LinA., RusnovR., WilsonB. C.Metronomic Photodynamic Therapy as a New Paradigm for Photodynamic Therapy: Rationale and Preclinical Evaluation of Technical Feasibility for Treating Malignant Brain Tumors. Photochem. Photobiol.80, 22–30 (2004).
63.
SchmidtM. H., MeyerG. A., ReichertK. W., ChengJ., KrouwerH. G., OzkerK., WhelanH. T.Evaluation of Photodynamic Therapy Near Functional Brain Tissue in Patients with Recurrent Brain Tumors. J. Neurooncol.67, 201–207 (2004).
64.
MarksP. V., BelchetzP. E., SaxenaA., IgbaseimokumoU., ThomsonS., NelsonM., StringerM. R., HolroydJ. A., BrownS. B.Effect of Photodynamic Therapy on Recurrent Pituitary Adenomas: Clinical Phase I/II Trial – An Early Report. Br. J. Neurosurg. 14, 317–325 (2000).
65.
KatoH., KonakaC., OnoJ., KawateN., NishimiyaK., ShinoharaH., SaitoM., SakaiH., NoguchiM., KitoT.Preoperative Laser Photodynamic Therapy in Combination with Operation in Lung Cancer. J. Thorac. Cardiovasc. Surg.90, 420–429 (1985).
MathurP. N., EdellE., SutedjaT., VergnonJ.Treatment of Early Stage Non-small Cell Lung Cancer. Chest123, 176s–180s (2003).
68.
KatoH., HaradaM., IchinoseS., UsudaJ., TsuchidaT., OkunakaT.Photodynamic Therapy (PDT) of Lung Cancer: Experience of the Tokyo Medical University. Photodiag. Photodyn. Therapy1, 49–55 (2004).
69.
McCaughanJ. S.Jr.Survival After Photodynamic Therapy to Non-pulmonary Metastatic Endobronchial Tumors. Lasers Surg. Med.24, 194–201 (1999).
KatoH., FurukawaK., SatoM., OkunakaT., KusunokiY., KawaharaM., FukuokaM., MiyazawaT., YanaT., MatsuiK., ShiraishiT., HorinouchiH.Phase II Clinical Study of Photodynamic Therapy Using Mono-L-aspartyl Chlorin e6 and Diode Laser for Early Superficial Squamous Cell Carcinoma of the Lung. Lung Cancer42, 103–111 (2003).
72.
MoghissiK.Role of Bronchoscopic Photodynamic Therapy in Lung Cancer Management. Curr. Opin. Pulm. Med.10, 256–260 (2004).
73.
PassH. I., TemeckB. K., KrandaK., ThomasG., RussoA., SmithP., FriaufW., SteinbergS. M.Phase III Randomized Trial of Surgery With or Without Intraoperative Photodynamic Therapy and Postoperative Immunochemotherapy for Malignant Pleural Mesothelioma. Ann. Surg. Oncol.4, 628–633 (1997).
74.
MoskalT. L., DoughertyT. J., UrschelJ. D., AntkowiakJ. G., RegalA. M., DriscollD. L., TakitaH.Operation and Photodynamic Therapy for Pleural Mesothelioma: 6-year Follow-up. Ann. Thorac. Surg.66, 1128–1133 (1998).
75.
SchouwinkH., RutgersE. T., van der SijpJ., OppelaarH., van ZandwijkN., van VeenR., BurgersS., StewartF. A., ZoetmulderF., BaasP.Intraoperative Photodynamic Therapy After Pleuropneumonectomy in Patients with Malignant Pleural Mesothelioma: Dose Finding and Toxicity Results. Chest120, 1167–1174 (2001).
76.
BonnetteP., HecklyG. B., VilletteS., FragolaA.Intraoperative Photodynamic Therapy After Pleuropneumonectomy for Malignant Pleural Mesothelioma. Chest122, 1866–1867 (2002).
77.
HahnS. M., SmithR. P., FriedbergJ.Photodynamic Therapy for Mesothelioma. Curr. Treat. Options Oncol.2, 375–383 (2001).
78.
ChenQ., HuangZ., ChenH., ShapiroH., BeckersJ., HetzelF. W.Improvement of Tumor Response by Manipulation of Tumor Oxygenation During Photodynamic Therapy. Photochem. Photobiol.76, 197–203 (2002).
MatziV., MaierA., SankinO., LindenmannJ., WoltcheM., SmolleJ., Smolle-JuttnerF. M.Photodynamic Therapy Enhanced by Hyperbaric Oxygenation in Palliation of Malignant Pleural Mesothelioma: Clinical Experience. Photodiag. Photodyn. Therapy1, 57–64 (2004).
81.
WoodburnK., FanQ., KesselD., WrightM., ModyT. D., HemmiG., MagdaD., SesslerJ. L., DowW. C., MillerR. A., YoungS. W.Phototherapy of Cancer and Atheromatousplaque with Texaphyrins. J. Clin. Laser Med. Surg.14, 343–348 (1996).
82.
RocksonS. G., KramerP., RazaviM., SzubaA., FilardoS., FitzgeraldP., CookeJ. P., YousufS., DeVaultA. R., RenschlerM. F., AdelmanD. C.Photoangioplasty for Human Peripheral Atherosclerosis: Results of a Phase I Trial of Photodynamic Therapy with Motexafin Lutetium (Antrin). Circulation102, 2322–2324 (2000).
83.
KereiakesD. J., SzyniszewskiA. M., WahrD., HerrmannH. C., SimonD. I., RogersC., KramerP., ShearW., YeungA. C., ShunkK. A., ChouT. M., PopmaJ., FitzgeraldP., CarrollT. E., ForerD., AdelmanD. C.Phase I Drug and Light Dose-escalation Trial of Motexafin Lutetium and Far Red Light Activation (phototherapy) in Subjects with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention and Stent Deployment: Procedural and Long-term Results. Circulation108, 1310–1315 (2003).
84.
CheungJ., ToddM., TurnbullR., AllisonB., MorninL., CarvalhoA. M., SpurrG., HsiangY.Longer Term Assessment of Photodynamic Therapy for Intimal Hyperplasia: A Pilot Study. J. Photochem. Photobiol. B. Biol.73, 141–147 (2004).
85.
EllC., GossnerL., MayA., SchneiderH. T., HahnE. G., StolteM., SrokaR.Photodynamic Ablation of Early Cancers of the Stomach by Means of mTHPC and Laser Irradiation: Preliminary Clinical Experience. Gut43, 345–349 (1998).
86.
BerrF.Photodynamic Therapy for Cholangiocarcinoma. Semin. Liver Dis.24, 177–187 (2004).
87.
WebberJ., FrommD.Photodynamic Therapy for Carcinoma In Situ of the Anus. Arch. Surg.139, 259–261 (2004).
88.
WiedmannM. W., CacaK.General Principles of Photodynamic Therapy (PDT) and Gastrointestinal Applications. Curr. Pharm. Biotechnol. 5, 397–408 (2004).
89.
WangK. K., KimJ. Y.Photodynamic Therapy in Barrett's Esophagus. Gastrointest. Endosc. Clin. N. Am.13, 483–489 (2003).
90.
PanjehpourM., OverholtB. F., PhanM. N., HaydekJ. M.Optimization of Light Dosimetry for Photodynamic Therapy of Barrett's Esophagus: Efficacy vs. Incidence of Stricture After Treatment. Gastrointest. Endosc.61, 13–18 (2005).
91.
OrtnerM. A.Photodynamic Therapy in Cholangiocarcinoma: An Overview Photodiag. Photodyn. Therapy1, 85–92 (2004).
92.
OrtnerM. A., CacaK., BerrF., LiebetruthJ., MansmannU., HusterD., VoderholzerW., SchachschalG., MossnerJ., LochsH.Successful Photodynamic Therapy for Nonresectable Cholangiocarcinoma: A Randomized Prospective Study. Gastroenterol. 125, 1355–1363 (2003).
93.
HarewoodG. C., BaronT. H., RumallaA., WangK. K., GoresG. J., StadheimL. M., de GroenP. C.Pilot Study to Assess Patient Outcomes Following Endoscopic Application of Photodynamic Therapy for Advanced Cholangiocarcinoma. J. Gastroenterol. Hepatol.20, 415–420 (2005).
94.
WiedmannM., BerrF., SchiefkeI., WitzigmannH., KohlhawK., MossnerJ., CacaK.Photodynamic Therapy in Patients with Nonresectable Hilar Cholangiocarcinoma: 5-year Follow-up of a Prospective Phase II Study. Gastrointest. Endosc.60, 68–75 (2004).
95.
WiedmannM., CacaK., BerrF., SchiefkeI., TannapfelA., WittekindC., MossnerJ., HaussJ., WitzigmannH.Neoadjuvant Photodynamic Therapy as a New Approach to Treating Hilar Cholangiocarcinoma: A Phase II Pilot Study. Cancer97, 2783–2790 (2003).
96.
NanashimaA., YamaguchiH., ShibasakiS., IdeN., SawaiT., TsujiT., HidakaS., SumidaY., NakagoeT., NagayasuT.Adjuvant Photodynamic Therapy for Bile Duct Carcinoma After Surgery: A Preliminary Study. J. Gastroenterol. 39, 1095–1101 (2004).
AyaruL., BownS. G., PereiraS. P.Photodynamic Therapy for Pancreatic and Biliary Tract Carcinoma. Int. J. Gastrointest. Cancer35, 1–14 (2005).
99.
BownS. G., RogowskaA. Z., WhitelawD. E., LeesW. R., LovatL. B., RipleyP., JonesL., WyldP., GillamsA., HatfieldA. W. R.Photodynamic Therapy for Cancer of the Pancreas. Gut50, 549–557 (2002).
100.
WaltherM. M., DelaneyT. F., SmithP. D., FriaufW. S., ThomasG. F., ShawkerT. H., VargasM. P., ChoykeP. L., LinehanW. M., AbrahamE. H., OkunieffP. G., GlatsteinE.Phase I Trial of Photodynamic Therapy in the Treatment of Recurrent Superficial Transitional Cell Carcinoma of the Bladder. Urology50, 199–206 (1997).
101.
NseyoU. O., ShumakerB., KleinE. A., SutherlandK.Photodynamic Therapy Using Porfimer Sodium as an Alternative to Cystectomy in Patients with Refractory Transitional Cell Carcinoma In Situ of the Bladder. J. Urol.160, 39–44 (1998).
102.
ManyakM. J., OganK.Photodynamic Therapy for Refractory Superficial Bladder Cancer: Long-term Clinical Outcomes of Single Treatment Using Intravesical Diffusion Medium. J. Endourol. 17, 633–639 (2003).
103.
McBridgeG.Studies Expand Potential Uses of Photodynamic Therapy. J. Natl. Cancer Inst.94, 1740–1742 (2002).
104.
KriegmairM., BaumgartnerR., LumperW., WaidelichR., HofstetterA.Early Clinical Experience with 5-aminolevulinic Acid for the Photodynamic Therapy of Superficial Bladder Cancer. Br. J. Urol.77, 667–671 (1996).
105.
BergerA. P., SteinerH., StenzlA., AkkadT., BartschG., HoltlL.Photodynamic Therapy with Intravesical Instillation of 5-aminolevulinic Acid for Patients with Recurrent Superficial Bladder Cancer: A Single-center Study. Urology61, 338–341 (2003).
106.
WaidelichR., SteppH., BaumgartnerR., WeningerE., HofstetterA., KriegmairM.Clinical Experience with 5-aminolevulinic Acid and Photodynamic Therapy for Refractory Superficial Bladder Cancer. J. Urol.165, 1904–1907 (2001).
107.
WaidelichR., BeyerW., KnuchelR., SteppH., BaumgartnerR., SchroderJ., HofstetterA., KriegmairM.Whole Bladder Photodynamic Therapy with 5-aminolevulinic Acid Using a White Light Source. Urology61, 332–337 (2003).
108.
ShackleyD. C., BriggsC., GilhooleyA., WhitehurstC., O'FlynnK. J., BettsC. D., MooreJ. V., ClarkeN. W.Photodynamic Therapy for Superficial Bladder Cancer Under Local Anaesthetic. B. J. Urol. Int.89, 665–670 (2002).
109.
WhitehurstC., PantelidesM. L., MooreJ. V., BlacklockN. J.Optimization of Multifiber Light Delivery for the Photodynamic Therapy of Localized Prostate Cancer. Photochem. Photobiol.58, 589–593 (1993).
110.
MuschterR.Photodynamic Therapy: A New Approach to Prostate Cancer. Curr. Urol. Rep.4, 221–228 (2003).
111.
NathanT. R., WhitelawD. E., ChangS. C., LeesW. R., RipleyP. M., PayneH., JonesL., ParkinsonM. C., EmbertonM., GillamsA. R., MundyA. R., BownS. G.Photodynamic Therapy for Prostate Cancer Recurrence after Radiotherapy: A Phase I Study. J. Urol.168, 1427–1432 (2002).
112.
ZaakD., SrokaR., HöppnerM., KhoderW., ReichO., TritschlerS., MuschterR., KnüchelR., HofstetterA.Photodynamic Therapy by Means of 5-ALA Induced PPIX in Human Prostate Cancer – Preliminary Results. Med. Laser Appl.18, 91–95 (2003).
113.
StrippD. C. H., MickR., ZhuT. C., WhittingtonR., SmithD., DimofteA., FinlayJ., MilesJ., BuschT. M., Shin1D., KachurA., TochnerZ. A., MalkowiczS. B., GlatsteinE., HahnS. M.Phase I Trial of Motexafin Lutetium-Mediated Interstitial Photodynamic Therapy in Patients with Locally Recurrent Prostate Cancer. Proc. of SPIE5315, 88–99 (2004).
114.
GertnerM. R., BogaardsA., WeersinkR. A., McCluskeyS. A., HaiderM. A., YueC. K. K., SavardJ., SimpsonS., BrunP. H., CohenP., ScherzA., SalomonY., AprikianA. G., ElhilaliM. M., WilsonB. C., TrachtenbergJ.Initial Results of a Phase I/II Trial of WST09-mediated Photodynamic Therapy (WST09-PDT) for Recurrent Prostate Cancer Following Failed External Beam Radiation Therapy (EBRT). Eur. Urol. Suppl.3, 212 (2004).
115.
JankunJ., LilgeL., DouplikA., KeckR. W., PestkaM., SzkudlarekM., StevensP. J., LeeR. J., SelmanS. H.Optical Characteristics of the Canine Prostate at 665 nm Sensitized with Tin Etiopurpurin Dichloride: Need for Real-time Monitoring of Photodynamic Therapy. J. Urol.172, 739–743 (2004).
116.
ZhuT. C., DimofteA., FinlayJ. C., StrippD., BuschT., MilesJ., WhittingtonR., MalkowiczS. B., TochnerZ., GlatsteinE., HahnS. M.Optical Properties of Human Prostate at 732 nm Measured In Vivo During Motexafin Lutetium-mediated Photodynamic Therapy. Photochem. Photobiol.81, 96–105 (2005).
117.
MartinN. E., HahnS. M.Interstitial Photodynamic Therapy for Prostate Cancer: A Developing Modality. Photodiag. Photodyn. Therapy1, 123–136 (2004).
118.
WeersinkR. A., BogaardsA., GertnerM., DavidsonS. R. H., ZhangK., NetchevG., TrachtenbergT., WilsonB. C.Techniques for Delivery and Monitoring of TOOKAD (WST09)-mediated Photodynamic Therapy of the Prostate: Clinical Experience and Practicalities. Photochem. Photobiol. Sci. (in press) (2005).
119.
DoleK. C., ChenQ., HetzelF. W., WhalenL. R., BlancD., HuangZ.Effects of Photodynamic Therapy on Peripheral Nerve: In Situ Compound-action Potentials Study in a Canine Model. Photomed. Laser Surg.23, 172–176 (2005).
120.
HuangZ., ChenQ., TrncicN., LaRueS. M., BrunP. H., WilsonB. C., ShapiroH., HetzelF. W.Effects of Pd-bacteriopheophorbide (TOOKAD)-mediated Photodynamic Therapy on Canine Prostate Pretreated with Ionizing Radiation. Radiat. Res.161, 723–731 (2004).
121.
ChenQ., HuangZ., LuckD., BeckersJ., BrunP. H., WilsonB. C., ScherzA., SalomonY., HetzelF. W.Preclinical Studies in Normal Canine Prostate of a Novel Palladium-bacteriopheophorbide (WST09) Photosensitizer for Photodynamic Therapy of Prostate Cancers. Photochem. Photobiol.76, 438–445 (2002).
122.
HuangZ., ChenQ., LuckD., BeckersJ., WilsonB. C., TrncicN., LaRueS. M., BlancD., HetzelF. W.Studies of a Vascular-acting Photosensitizer, Pd-bacteriopheophorbide (Tookad), in Normal Canine Prostate and Spontaneous Canine Prostate Cancer. Lasers Surg. Med. (in press) (2005).
123.
SelmanS. H., KeckR. W.The Effect of Transurethral Light on the Canine Prostate After Sensitization with the Photosensitizer Tin (II) Etiopurpurin Dichloride: A Pilot Study. J. Urol.152, 2129–2132 (1994).
124.
MuroyaT., SuehiroY., UmayaharaK., AkiyaT., IwabuchiH., SakunagaH., SakamotoM., SugishitaT., TenjinY.Photodynamic Therapy (PDT) for Early Cervical Cancer. Gan To Kagaku Ryoho23, 47–56 (1996). (in Japanese).
125.
MonkB. J., BrewerC., Van NostrandK., BernsM. W., McCulloughJ. L., TadirY., ManettaA.Photodynamic Therapy Using Topically Applied Dihematoporphyrin Ether in the Treatment of Cervical Intraepithelial Neoplasia. Gynecol. Oncol.64, 70–75 (1997).
126.
HillemannsP., KorellM., Schmitt-SodyM., BaumgartnerR., BeyerW., KimmigR., UntchM., HeppH.Photodynamic Therapy in Women with Cervical Intraepithelial Neoplasia Using Topically Applied 5-aminolevulinic Acid. Int. J. Cancer81, 34–38 (1999).
127.
KeefeK. A., TadirY., TrombergB., BernsM., OsannK., HashadR., MonkB. J.Photodynamic Therapy of High-grade Cervical Intraepithelial Neoplasia with 5-aminolevulinic Acid. Lasers Surg. Med.31, 289–293 (2002).
128.
BarnettA. A., HallerJ. C., CairnduffF., LaneG., BrownS. B., RobertsD. J.A Randomised, Double-blind, Placebo-controlled Trial of Photodynamic Therapy using 5-aminolaevulinic Acid for the Treatment of Cervical Intraepithelial Neoplasia. Int. J. Cancer103, 829–832 (2003).
129.
ChenW. R., HuangZ., KorbelikM., NordquistR. E., LiuH.Photoimmunotherapy for Cancer Treatment. J. Environ. Pathol. Toxicol. Oncol. (in press) (2005).
